Startup entity
funding is the sole category represented across all 1 tracked stories. ASX is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. We currently track 1 Startup story that mention Vitalant, all published on June 12, 2026.
Last mentioned: Jun 12, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
funding is the sole category represented across all 1 tracked stories. ASX is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. We currently track 1 Startup story that mention Vitalant, all published on June 12, 2026. Each carries 2 original sources on average.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 7 Startup stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Vitalant. Shared-story counts are live from our verified record — not editorial picks.
Vitrafy Life Sciences raised $30 million in a discounted institutional placement, aiming to disrupt the US blood storage market with its Guardion integrated platform. The raise, at a 31.6% discount, funds fleet expansion and US sales ahead of a 2027 legacy technology phase-out.
Source: proactiveinvestors.com · smallcaps.com.au
Vitalant is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
